Imugene Highlights Recent Achievements and Looks Ahead to Key Upcoming Immuno-oncology Catalysts Imugene Limited (ASX: IMU), a clinical stage immuno-oncology company, highlighted recent progress across the company's immuno-oncology portfolio.